These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11025617)

  • 61. Tilt balance towards regulation: evolving new strategy for treatment of hemophilia inhibitors.
    Miao CH
    J Thromb Haemost; 2011 Aug; 9(8):1521-3. PubMed ID: 21649848
    [No Abstract]   [Full Text] [Related]  

  • 62. A follow-up study of the T-helper and T-suppressor-cytotoxic cell populations (greater than one year) in 39 hemophiliacs.
    Aznar JA; Carbonell F; Jorquera JI; Montoro JM; Carmona E; Puig N; Trenor A; Gonzalez-Molina A
    Thromb Haemost; 1985 Dec; 54(4):903. PubMed ID: 2868544
    [No Abstract]   [Full Text] [Related]  

  • 63. Human antibodies to recombinant factor VII in hemophiliacs.
    Lusher JM
    J Interferon Res; 1994 Aug; 14(4):173-4. PubMed ID: 7822865
    [No Abstract]   [Full Text] [Related]  

  • 64. Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice.
    ter Avest PC; Fischer K; Mancuso ME; Santagostino E; Yuste VJ; van den Berg HM; van der Bom JG;
    J Thromb Haemost; 2008 Dec; 6(12):2048-54. PubMed ID: 18983511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A.
    Castaman G; Fijnvandraat K
    Blood; 2014 Oct; 124(15):2333-6. PubMed ID: 25139352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The treatment of hemophilia--a double-edged sword.
    Madhok R
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):2-6. PubMed ID: 8266118
    [No Abstract]   [Full Text] [Related]  

  • 67. Home infusion--the new approach.
    Vaugh E
    Health Care (Don Mills); 1980 Oct; 22(10):44, 46. PubMed ID: 10318526
    [No Abstract]   [Full Text] [Related]  

  • 68. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
    Hu G; Guo D; Key NS; Conti-Fine BM
    Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A; Roisenberg I
    Thromb Haemost; 1999 Mar; 81(3):475-6. PubMed ID: 10102489
    [No Abstract]   [Full Text] [Related]  

  • 71. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
    Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
    Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disappearance of FVIII inhibitors in a severe hemophilia A neonate after steroid treatment correlated with a cytokine shift toward a T-helper 2 pattern.
    Vianello F; Zanon E; Zerbinati P; Innella B; Girolami A
    Haematologica; 2000 Oct; 85(10):1114-5. PubMed ID: 11025617
    [No Abstract]   [Full Text] [Related]  

  • 73. Endocytic receptor for pro-coagulant factor VIII: relevance to inhibitor formation.
    Navarrete AM; Dasgupta S; Teyssandier M; Repesse Y; Delignat S; André S; Bayry J; Kaveri SV; Lacroix-Desmazes S
    Thromb Haemost; 2010 Dec; 104(6):1093-8. PubMed ID: 20886186
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunobiology of inhibitor development in hemophilia A.
    Fijnvandraat K; Bril WS; Voorberg J
    Semin Thromb Hemost; 2003 Feb; 29(1):61-8. PubMed ID: 12640567
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.